Phreesia Inc
NYSE:PHR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.05
32.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Phreesia Inc
Phreesia Inc., an innovator in the healthcare sector, has carved a niche for itself by redefining how medical practices manage patient intake and engagement. Instead of the traditional, cumbersome, and paper-laden check-in process, Phreesia offers a seamless digital solution. This cloud-based platform empowers healthcare providers by digitizing the registration process, thus enhancing operational efficiency and improving patient experiences. Clinics and hospitals leverage Phreesia's intuitive tablets and mobile solutions, allowing patients to update their information, complete questionnaires, and handle co-payments before even seeing their doctors. It's a technical orchestration that streamlines workflows and frees medical staff to focus more on patient care innovations.
Revenue for Phreesia is generated primarily through a subscription-based model where healthcare providers pay for access to this comprehensive platform. The company offers a menu of services, with added features like robust data analytics, appointment reminder systems, and insurance verification processes. These value-added services not only enhance administrative tasks but also provide actionable insights into patient trends and practice performance. Through strategic partnerships and integrations with various electronic health record (EHR) systems, Phreesia embeds itself deeply into healthcare operations, making its platform indispensable to modern medical practices where patient experience meets cutting-edge technology.
Phreesia Inc., an innovator in the healthcare sector, has carved a niche for itself by redefining how medical practices manage patient intake and engagement. Instead of the traditional, cumbersome, and paper-laden check-in process, Phreesia offers a seamless digital solution. This cloud-based platform empowers healthcare providers by digitizing the registration process, thus enhancing operational efficiency and improving patient experiences. Clinics and hospitals leverage Phreesia's intuitive tablets and mobile solutions, allowing patients to update their information, complete questionnaires, and handle co-payments before even seeing their doctors. It's a technical orchestration that streamlines workflows and frees medical staff to focus more on patient care innovations.
Revenue for Phreesia is generated primarily through a subscription-based model where healthcare providers pay for access to this comprehensive platform. The company offers a menu of services, with added features like robust data analytics, appointment reminder systems, and insurance verification processes. These value-added services not only enhance administrative tasks but also provide actionable insights into patient trends and practice performance. Through strategic partnerships and integrations with various electronic health record (EHR) systems, Phreesia embeds itself deeply into healthcare operations, making its platform indispensable to modern medical practices where patient experience meets cutting-edge technology.
First Net Income: Phreesia reported its first ever quarter of positive net income, reaching $700,000 for Q2 FY26.
AccessOne Acquisition: Announced the $160 million cash acquisition of AccessOne, expected to add $35 million in revenue and $11 million in adjusted EBITDA annually, and to close in Q3 or early Q4 FY26.
Revenue Growth: Q2 revenue was $117.3 million, up 15% year-over-year, in line with company expectations.
Cash Flow Strength: Achieved positive operating and free cash flow for the fourth consecutive quarter.
Guidance Raised: Fiscal 2026 adjusted EBITDA guidance increased to $87–92 million (from $85–90 million); revenue guidance maintained at $472–482 million.
TAM Expansion: Total addressable market (TAM) increased significantly to about $24 billion, driven by AccessOne and increased potential in network solutions.
AI Product Traction: Voice AI and other new AI-driven products are rolling out, receiving strong feedback and beginning to generate revenue.
No Risk on Patient Financing: For AccessOne, Phreesia will not bear financial risk on patient payment plans; risk is shared by PNC Bank and providers.